ATTIRE: Albumin To prevenT Infection in chronic liveR failurE: study protocol for an interventional randomised controlled trial

Overview of attention for article published in BMJ Open, October 2018

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (83rd percentile)
Good Attention Score compared to outputs of the same age and source (72nd percentile)

Mentioned by

blogs: 1 blog

twitter: 7 X users

Readers on

mendeley: 46 Mendeley

So far, Altmetric has seen 7 X posts from 7 X users, with an upper bound of 37,976 followers.

RT @LeonardoSotoMu: (6/6) No hay una recomendación formal de proteger la infusión de albúmina al 20% de la luz, sin embargo los frascos de…

(6/6) No hay una recomendación formal de proteger la infusión de albúmina al 20% de la luz, sin embargo los frascos de vidrio deben estar resguradados. En el ATTITRE trial se uso una velocidad 100 mL/hora (1 hora) https://t.co/s1Ia1XjbdQ https://t.co/77Y1…

Analysis well underway...should have the abstract ready for #EASL2020 late breakers deadline...lips are sealed until then!

@ebtapper @john_ricemd @rrosenblattmd @AGA_CGH @DrLChina Well, primary endpoint is a composite of new infection, renal dysfunction, or death (https://t.co/A1KPP9RxoC) My prior is that the clinical benefit of albumin is limited and I don't think we will…

This page shows the most recent X posts that mention this research output. Click here to find out how to access more activity, including 3 additional X posts.